NUS — Nu Skin Enterprises, Inc.

Nu Skin Enterprises Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 2025 Revenue: $370 million, within guidance; impacted by $1 million foreign currency headwind.
• Earnings Per Share (EPS): $0.29, in line with expectations.
• Full Year 2025 Revenue: $1.49 billion, consistent with guidance; foreign currency headwind of approximately $13.4 million.
• Adjusted EPS for 2025: $1.27, up 51% from $0.84 in 2024.
• Gross Margin: Q4 at 70.7%, down from 71.4% YoY; core Nu Skin gross margin at 77.6%, up 100 basis points YoY.
• Operating Margin: 6.3% for Q4; adjusted operating margin for the year at 6.7%, up 140 basis points YoY.
• Cash Flow: $80.3 million from operations; $240 million in cash and $224 million in debt, indicating a strong balance sheet.

2. Strategic Updates and Business Highlights

• Transformation Focus: Emphasis on becoming a leading intelligent beauty, wellness, and lifestyle platform.
• Prysm iO Launch: Introduction of an intelligent wellness platform aimed at enhancing customer engagement and lifetime value; targeting placement of over 100,000 devices by year-end 2026.
• Expansion into India: Premarket operations initiated in November 2025, with a formal launch expected in late 2026; strategic focus on local manufacturing and digital infrastructure.
• Emerging Market Growth: Continued success in Latin America and plans for expansion into India, leveraging insights from existing operations.

3. Forward Guidance and Outlook

• 2026 Revenue Projection: Expected between $1.35 billion and $1.5 billion, with a foreign exchange headwind of $13 million to $15 million.
• 2026 EPS Guidance: Anticipated between $0.80 and $1.20, reflecting a higher expected tax rate of 35%.
• Q1 2026 Revenue Guidance: Projected between $320 million and $340 million, historically the lowest quarter due to seasonality.

4. Bad News, Challenges, or Points of Concern

• Gross Margin Decline: Slight decrease in Q4 gross margin due to promotional activities; ongoing pressures from competitive pricing and market dynamics.
• Operational Transition Costs: Transitioning to new business practices may incur switching costs into early 2026, impacting short-term performance.
• Market Entry Risks: Entering India presents challenges, including high import duties and the need for robust local infrastructure; cautious revenue forecasts reflect these uncertainties.

5. Notable Q&A Insights

• Prysm iO Revenue Potential: While initial device sales are projected at $30 million, the subscription revenue model remains uncertain as the company is still learning about customer uptake.
• India Market Strategy: Emphasis on establishing local manufacturing and logistics; cautious optimism about long-term potential despite acknowledging longer sales cycles.
• Operational Leverage: Management is focused on aligning G&A expenses with revenue growth while maintaining a flexible cost structure to support strategic initiatives.

Overall, Nu Skin's Q4 2025 results reflect a solid financial performance amid ongoing strategic transformations, with a focus on innovative product launches and market expansion, albeit tempered by operational challenges and market entry risks.